CD8A and neoplasm: Collectively, Ad-CAIX/Ad-PD-L1 vaccine could effectively inhibit tumor growth or lung metastasis in the subcutaneous, lung metastasis, and orthotropic tumor models by DCs-mediated CD8+ T cell anti-tumor immune responses (Fig. 7).